Compare VIVO & KYNB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIVO | KYNB |
|---|---|---|
| Founded | 2014 | 1993 |
| Country | United Kingdom | United States |
| Employees | N/A | N/A |
| Industry | Power Generation | Biotechnology: Pharmaceutical Preparations |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 37.5M | 31.9M |
| IPO Year | N/A | N/A |
| Metric | VIVO | KYNB |
|---|---|---|
| Price | $2.92 | $7.10 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 865.1K | 8.3K |
| Earning Date | 05-23-2026 | 05-04-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | N/A | N/A |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $0.15 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.97 | $6.32 |
| 52 Week High | $4.27 | $9.58 |
| Indicator | VIVO | KYNB |
|---|---|---|
| Relative Strength Index (RSI) | 51.83 | 50.43 |
| Support Level | $1.97 | $7.04 |
| Resistance Level | $3.50 | $7.50 |
| Average True Range (ATR) | 0.44 | 0.21 |
| MACD | -0.01 | 0.00 |
| Stochastic Oscillator | 24.14 | 44.19 |
Kyntra Bio Inc is a biopharmaceutical company focused on the development of novel therapies in oncology and rare disease. The company's research programs target cancer and rare disease indications, including anemia associated with lower-risk myelodysplastic syndrome (LR-MDS) and metastatic castration-resistant prostate cancer (mCRPC). Itd pipeline drug candidates include Roxadustat and FG-3246.